Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
03.04.2013 17:57:00

Essilor: 2012 Registration Document Filed

Regulatory News:

The 2012 Essilor (Paris:EI) Registration Document was filed in French version with the Autorité des Marchés Financiers (AMF) on April 2, 2013 under the number D.13-0252. The Registration Document includes:

a) The Annual Financial Report, with:

  • The parent company financial statements;
  • The consolidated financial statements;
  • A management report containing information in compliance with articles L.225-100, L.225-100-3, L.225-11 (§ 2) and L.225-100-2 of the French Commercial Code;
  • A statement by the persons responsible for the Registration Document;
  • The report of the Auditors on the parent company and consolidated financial statements;
  • Information concerning Auditors’ fees.

b) The Chairman’s report on corporate governance and internal control.

c) The description of the share buyback program.

From now on, the French version is available to the public free of charge, as provided for in applicable legislation, and may be viewed on Essilor’s corporate website www.essilor.com. The English version will be available in a few days.

About Essilor

The world’s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique vision requirements. To support this mission, the Company allocates more than €150 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Essilor’s flagship brands are Varilux®, Crizal®, Definity®, Xperio®, OptifogTM and Foster Grant®. It also develops and markets equipment, instruments and services for eyecare professionals.

Essilor reported consolidated revenue of approximately €5 billion in 2012 and employs around 50,700 people in some 100 countries. It operates 22 plants, more than 400 prescription laboratories and edging facilities, as well as several research and development centers around the world.

For more information, please visit www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.

Codes and symbols: ISIN: FR FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

EURO STOXX 50 4 789,08 0,70%
CAC 40 7 255,01 0,58%
EURONEXT 100 1 443,61 0,62%
EURO STOXX 497,32 0,78%
SBF 120 5 501,59 0,59%
Next CAC 70 3 519,63 -0,50%